SIRT1 and lung cancer: Here we support the SIRT1's role in chemoresistance in some types of lung cancer cells and demonstrate that using SIRT1 inhibitor to treat a certain type of lung cancer showing acquired NER capacity would be beneficial for cancer treatment.